Targeting parathyroid hormone level in diabetic patients with stage 3 to 5 chronic kidney disease: Does metabolic syndrome matter?

Journal of Renal Nutrition

Volumn 21, Issue 3, 2011, Pages 219-225

  Elsurer, Rengin ^a   Afsar, Baris ^a   Guner, Ertugrul ^a   Yildiz, Idris ^a  

^a Zonguldak Ataturk State Hospital   (Turkey)

Author keywords

[No Author keywords available]

Indexed keywords

PARATHYROID HORMONE;

ADULT; ARTICLE; BLOOD; BLOOD PRESSURE; CHRONIC KIDNEY FAILURE; CROSS-SECTIONAL STUDY; FEMALE; HUMAN; MALE; METABOLIC SYNDROME X; MIDDLE AGED; NON INSULIN DEPENDENT DIABETES MELLITUS; PATHOPHYSIOLOGY;

ADULT; BLOOD PRESSURE; CROSS-SECTIONAL STUDIES; DIABETES MELLITUS, TYPE 2; FEMALE; HUMANS; KIDNEY FAILURE, CHRONIC; MALE; METABOLIC SYNDROME X; MIDDLE AGED; PARATHYROID HORMONE;

EID: 79955119743     PISSN: 10512276     EISSN: None     Source Type: Journal    
DOI: 10.1053/j.jrn.2010.04.006     Document Type: Article

References (16)

1. Reis J.P., von Mühlen D., Miller E.R. Relation of 25-hydroxyvitamin D and parathyroid hormone levels with metabolic syndrome among US adults. Eur J Endocrinol 2008, 159:41-48.
2. Reis J.P., von Mühlen D., Kritz-Silverstein D., et al. Vitamin D, parathyroid hormone levels, and the prevalence of metabolic syndrome in community dwelling older adults. Diabetes Care 2007, 30:1549-1555.
3. Inaba M., Okuno S., Nagasue K., et al. Impaired secretion of parathyroid hormone is coherent to diabetic hemodialyzed patients. Am J Kidney Dis 2001, 38:S139-S142.
4. Report of the Expert Committee on the Diagnosis and Classification of Diabetes Mellitus. Diabetes Care 1997, 20:1183-1197.
5. Levey A.S., Bosch J.P., Lewis J.B., et al. A more accurate method to estimate glomerular filtration rate from serum creatinine: a new prediction equation. Modification of Diet in Renal Disease Study Group. Ann Intern Med 1999, 130:461-470.
6. Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults: Executive summary of the third report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III). JAMA 2001, 285:2486-2497.
7. K/DOQI clinical practice guidelines for chronic kidney disease: evaluation, classification, and stratification. Am J Kidney Dis 2002, 39:S1-S266.
8. Pei Y., Hercz G., Greenwood C., et al. Renal osteodystrophy in diabetic patients. Kidney Int 1993, 44:159-164.
9. Takahashi N., Kojima T., Ogawa H., et al. Correlation between parathyroid hormone, bone alkaline phosphatase and N-telopeptide of type 1 collagen in diabetic and non-diabetic haemodialysis patients. Nephrology (Carlton) 2007, 12:539-545.
10. Hjelmesaeth J., Hofsø D., Aasheim E.T., et al. Parathyroid hormone, but not vitamin D, is associated with the metabolic syndrome in morbidly obese women and men: a cross-sectional study. Cardiovasc Diabetol 2009, 8:7.
11. Kamycheva E., Sundsfjord J., Jorde R. Serum parathyroid hormone level is associated with body mass index. The 5th Tromsø study. Eur J Endocrinol 2004, 151:167-172.
12. Reinehr T., de Sousa G., Alexy U., et al. Vitamin D status and parathyroid hormone in obese children before and after weight loss. Eur J Endocrinol 2007, 157:225-232.
13. Jorde R., Sundsfjord J., Haug E., et al. Relation between low calcium intake, parathyroid hormone, and blood pressure. Hypertension 2000, 35:1154-1159.
14. Jorde R., Svartberg J., Sundsfjord J. Serum parathyroid hormone as a predictor of increase in systolic blood pressure in men. J Hypertens 2005, 23:1639-1644.
15. Lippi G., Montagnana M., Targher G., et al. Vitamin D, parathyroid hormone levels, and the prevalence of metabolic syndrome in community-dwelling older adults: response to Reis, et al. Diabetes Care 2007, 30:e135.
16. Inukai T., Fujiwara Y., Tayama K., et al. Alterations in serum levels of 1 alpha,25(OH)2 D3 and osteocalcin in patients with early diabetic nephropathy. Diabetes Res Clin Pract 1997, 38:53-59.